Navigation Links
Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site

The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help ( Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. The drug's manufacturer issued a nationwide Digitek recall after receiving several reports of injuries or illnesses among patients.

Austin, Texas (Vocus) September 23, 2008 -- The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help ( This site will serve as a news and information resource for patients who may have been prescribed the improperly manufactured Digitek (digoxin) tablets that were recently recalled by their maker, Actavis Totowa.

Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. Digitek and other digoxin drugs work by increasing the amount of calcium in the muscles of the heart, which helps to strengthen a patient’s heartbeat. These drugs also work to slow the signals which cause the heart to beat, decreasing the number of irregular heartbeats, or arrhythmias.

Actavis issued a nationwide [Digitek recall] on April 25, 2008 after receiving several reports of injuries or illnesses among patients who were taking the drug. According to a press release issued by the company, some Digitek tablets were improperly manufactured at twice their normal thickness. As a result, some patients who were prescribed Digitek may have inadvertently received a double-dose of the drug.

Because the difference between a safe and unsafe amount of Digitek is very small, taking these double-strength pills could cause patients to suffer an overdose due to digoxin toxicity. In some cases, patients who experience a Digitek overdose may suffer a heart attack, stroke or, potentially, death. Other side effects include dizziness and fainting, an irregular heartbeat, low blood pressure, confusion, vomiting, nausea or other symptoms.

In 2006 and 2007, the Food and Drug Administration sent warning letters to Actavis concerning violations of “Good Manufacturing Practices” at the New Jersey plant where Digitek was manufactured. The agency stated that because of these violations, products manufactured at the plant were “adulterated,” meaning that there was no way for the company to make sure that these drugs had the correct “identity, strength, quality and purity” before they were prescribed to patients.

Dozens of individuals who developed serious and potentially deadly injuries after suffering a Digitek overdose have already contacted an [attorney] about filing a lawsuit against Actavis Totowa and its distributors. These lawsuits have alleged that Digitek tablets were defectively manufactured at twice their normal dose by Actavis. Patients have also alleged that the company failed to heed safety warnings from the FDA about quality control issues at the plant where Digitek was produced, which may have contributed to the Digitek recall.

About Hissey Kientz, LLP [Hissey Kientz, LLP] is currently accepting cases involving individuals who may have been injured as a result of a Digitek overdose. Hissey Kientz, LLP also represents those who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by the Ortho Evra patch, Trasylol, the Composix Kugel mesh patch, the Duragesic patch (fentanyl), gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP ( or call toll-free at (866) 275-4454.


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
2. LifeMasters Announces Agreement to Offer Disease Management Services to High-Risk Wisconsin Residents
3. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
4. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
5. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
6. Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
7. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
8. CorVel Announces Expanded Share Buyback
9. Lucas Group Announces Their Military Hiring Conferences Schedule for September
10. Integrative Nutrition Announces Partnership with SUNY
11. iMedica Announces Agreement with Misys
Post Your Comments:
Related Image:
Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its ... exclusive list of CAAHEP accredited colleges, as only one of twelve colleges and universities ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 --> ... use SyMRI to find optimal contrast weighting of MRI ... and has signed a research agreement with SyntheticMR in order ... Using SyMRI, it is possible to generate multiple contrast images ... the patient has left, thus making it possible to both ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology: